Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
CTKBthis companyCytek Biosciences, Inc.	$5.91	-9.71×	1.89×	3.2×	-33.23×	-81.9%	51.8%	-20.0%	-33.0%	-19.5%	-10.3%	-1.4%	0.07×	3.86×	-85.2×	5.04×	0.0%	4	4.15	2	C+
AAgilent Technologies, Inc.	$175.11	31.89×	6.14×	5.96×	23.43×	-60.2%	52.4%	21.3%	18.8%	19.3%	12.6%	2.8%	0.5×	0.85×	13.21×	1.96×	0.7%	6	5.82	3	B+
BIOBio-Rad Laboratories, Inc.	$385.80	10.87×	1.11×	3.2×	7.65×	-146.4%	52.0%	10.5%	29.4%	10.2%	2.0%	4.5%	0.21×	0.83×	5.52×	5.62×	0.0%	7	3.65	3	B
BRKRBruker Corporation	$61.70	-314.07×	2.91×	2.08×	29.4×	-38.9%	45.9%	6.9%	-0.3%	-0.4%	-1.9%	0.2%	0.83×	5.76×	3.91×	1.73×	0.3%	5	2.75	1	C-
LABStandard BioTools Inc.	$0.64	-6.4×	1.15×	5.72×	-4.68×	-325.1%	49.9%	-109.3%	-87.8%	-17.7%	-12.2%	-16.9%	0.07×	1.02×	-3,588.65×	4.19×	0.0%	3	-0.44	2	C+
TXG10x Genomics, Inc.	$60.50	-46.6×	2.56×	3.17×	439.61×	-115.9%	69.1%	-17.2%	-6.8%	-5.5%	-12.3%	6.4%	0.2×	-80.9×	0×	4.46×	0.0%	3	23.85	1	C-
Peer median	—	-6.4×	2.56×	3.2×	23.43×	-115.9%	52.0%	6.9%	-0.3%	-0.4%	-1.9%	2.8%	0.21×	0.85×	3.91×	4.19×	0.0%	5	3.65	2	—